PDX Portal

Model Details

Patient Information for Model: HCI-013

Model Contact

Model: HCI-013
Model Contact: Alana Welm
Institution: HCI Breast PDX Program
Email: Alana.Welm@hci.utah.edu

Patient Information

Clinical Timeline

Color Keys:

Positive

Negative

N/A

Clinical Information at Collection

Clinical Biomarkers/Mutations at Collection

Pathology Information at Collection

Model Information for Model: HCI-013

Model Details - Initial Implantation of Patient Tissue

Biomarkers & Mutations

Model Details - Acceptable Conditions for Passaging

Mutations (Cancer Gene Census List)

Mutation data is currently not available.

CNV

Histology Information for Model: HCI-013

There are no histology images for this model.

Metastasis Information for Model: HCI-013

Patient

PDX

Abdomen

Adrenal gland

Bone

Bones

Brain

CTC

Chest

Chest wall

Contralateral Breast

Dura

Fallopian Tubes

Head

Kidney

Liver

Lung

Lymph node

Lymph nodes

Neck

Ovary

Pancreas

Pericardium

Peritoneal cavity

Peritoneum

Pleura

Pleural effusion

Shoulder

Skin

Spine

Spleen

Thoracic Spine

Thymus

Patient Treatment Information for Model: HCI-013

Event Id	Treatment	Treatment Setting	Age at Start	Age at End	Duration	Clinical Response
11	Leuprolide	Neoadjuvant	46.5	51.5	1825 days	Progressive disease
12	Letrozole	Neoadjuvant	46.5	50.58	1489 days	Progressive disease
13	Zolendronic Acid	Neoadjuvant	46.5	53.83	2675 days	Progressive disease
14	Radiation Bone	Neoadjuvant	50.67	50.75	29 days	Progressive disease
15	Tamoxifen	Neoadjuvant	50.58	51.25	245 days	Progressive disease
17	Aromasin	Neoadjuvant	51.33	51.5	62 days	Progressive disease
18	Cyclophosphamide, Fluorouracil	Neoadjuvant	51.41	51.48	26 days	Progressive disease
19	Methotrexate	Neoadjuvant	51.5	51.75	91 days	Progressive disease
20	Capcitabine	Neoadjuvant	51.91	52.25	124 days	Progressive disease
21	Paclitaxel	Neoadjuvant	52.25	52.75	183 days	Progressive disease
23	Abraxane	Neoadjuvant	52.75	52.91	58 days	Progressive disease
24	Radiation Spine	Neoadjuvant	52.25	52.33	29 days	Progressive disease
25	Radiation spine	Neoadjuvant	52.75	52.83	29 days	Progressive disease
27	Doxorubicin	Neoadjuvant	52.91	53.75	307 days	Progressive disease
29	Carboplatin, Gemcitabine	Neoadjuvant	53.83	53.91	29 days	Progressive disease